RE:RE:RE:RE:RE:RE:CD8+ TiLs and T-cell exhaustionDo you remember when Matt Coffey said that pelareorep was the "Swiss Army Knife" of immunotherapy? Well I have taken the time to explain the fundamentals of what this Swiss Army knife can do and how it can do it with other immuno-oncology agents such as immune checkpoint inhibitors, bispecifics, ADCs, CAR-T therapies and small molecules such as CDK4/6, P13KCA and PARP inhibitors, for example.